Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids

Carl Victor Asche1,2, Shelah Leader3, Craig Plauschinat4, Swetha Raparla1, Ming Yan1, Xiangyang Ye1, Dave Young11Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, Utah, 2Center for Outcomes Research, University of Illinois College of Medicine at Peoria, Peoria, I...

Full description

Bibliographic Details
Main Authors:	Asche CV, Leader S, Plauschinat C, Raparla S, Yan M, Ye X, Young D
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-03-01
Series:	International Journal of COPD
Online Access:	http://www.dovepress.com/adherence-to-current-guidelines-for-chronic-obstructive-pulmonary-dise-a9501

Similar Items

The Role of Dual Bronchodilation and the Conscientious Use of Inhaled Corticosteroid in COPD
by: Ricardo G. Figueiredo, et al.
Published: (2022-08-01)

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
by: Kozma Chris M, et al.
Published: (2011-12-01)

Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD
by: Bishwakarma R, et al.
Published: (2017-01-01)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
by: Cheng S, et al.
Published: (2017-07-01)

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations
by: Calverley PM, et al.
Published: (2016-02-01)

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
by: Koehorst-ter Huurne K, et al.
Published: (2016-07-01)

Inhaled corticosteroids in COPD.
by: Brightling, C, et al.
Published: (1999)

Combination long acting β agonists-inhaled corticosteroids versus dual bronchodilation: a real conflict?
by: Marco Candela
Published: (2014-10-01)

Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
by: Magdalena Humenberger, et al.
Published: (2018-10-01)

Uncovering the beneficial effects of inhaled bronchodilator in COPD: beyond forced spirometry
by: José Alberto Neder, et al.

Long-acting Bronchodilators in COPD Management: One or Two?
by: Konstantinos Kostikas, et al.
Published: (2023-01-01)

Bronchodilator treatment of stable COPD: long-acting anticholinergics
by: W. Vincken
Published: (2005-09-01)

Inhaled Corticosteroids and the Lung Microbiome in COPD
by: Holly R. Keir, et al.
Published: (2021-09-01)

Effective treatment of inhaled corticosteroid and bronchodilator for “lymphocytic interstitial pneumonia” in primary Sjögren's syndrome
by: Yuki Moriuchi, et al.
Published: (2024-01-01)

Associated Factors of Pneumonia in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Apart from the Use of Inhaled Corticosteroids
by: Rosario Lineros, et al.
Published: (2023-04-01)

Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease
by: James F Donohue, et al.
Published: (2011-01-01)

COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
by: Saha, S, et al.
Published: (2006)

The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
by: Park JW, et al.
Published: (2023-05-01)

The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease
by: Kyriakos Souliotis, et al.
Published: (2020-06-01)

Inhaled Bronchodilators and Corticosteroids in the Management of Bronchiolitis Obliterans due to Allogenic Hematopoietic Stem Cell Transplantation
by: Vasiliki Epameinondas Georgakopoulou, et al.
Published: (2022-05-01)

Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions.
by: Brian J Clouse, et al.
Published: (2016-01-01)

Inhaled corticosteroids in COPD (multiple letters) [1]
by: Hart, S, et al.
Published: (1999)

How inhaled corticosteroids target inflammation in COPD
by: Simon Lea, et al.
Published: (2023-10-01)

Rational use of inhaled corticosteroids for the treatment of COPD
by: Jennifer K. Quint, et al.
Published: (2023-07-01)

Association between poor therapy adherence to inhaled corticosteroids and tiotropium and morbidity and mortality in patients with COPD
by: Koehorst-ter Huurne K, et al.
Published: (2018-05-01)

"Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPD
by: Kostikas Konstantinos, et al.
Published: (2010-09-01)

COPD and Osteoporosis: Associated Factors in Patients Treated with Inhaled Corticosteroids
by: Ozcakir S, et al.
Published: (2020-10-01)

Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
by: Kang J, et al.
Published: (2017-12-01)

Gaps In using bronchodilators, inhaled corticosteroids and influenza vaccine among 23 high- and low-income sites
by: Gnatiuc, L, et al.
Published: (2015)

Pembrolizumab-associated bronchiolitis in an elderly lung cancer patient required the treatment with an inhaled corticosteroid, erythromycin and bronchodilators
by: Takafumi Yamaya, et al.
Published: (2019-01-01)

The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease
by: Kliber Agnes, et al.
Published: (2010-05-01)

Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
by: Avdeev S, et al.
Published: (2019-06-01)

COPD - moving beyond bronchodilation
by: Swiss Medical Weekly
Published: (2007-03-01)

Bronchodilators use in patients with COPD
by: Dong YH, et al.
Published: (2015-09-01)

Cardiovascular morbidity and the use of inhaled bronchodilators
by: Christine Macie, et al.
Published: (2008-03-01)

Inhaled Corticosteroids in Subjects with Chronic Obstructive Pulmonary Disease: An Old, Unfinished History
by: Andrea S. Melani, et al.
Published: (2024-02-01)

Inhaled corticosteroids in chronic obstructive pulmonary disease: Moving toward precision medicine
by: Ashutosh Nath Aggarwal
Published: (2019-01-01)

Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD
by: Donohue JF, et al.
Published: (2019-12-01)

Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
by: Yang HH, et al.
Published: (2017-08-01)

Improving adherence with inhaler therapy in COPD
by: Suzanne C Lareau, et al.
Published: (2010-11-01)